Sonia Vallet Selected Research

Sonia Vallet Research Topics

Disease

35	Multiple Myeloma 10/2021 - 06/2005
23	Neoplasms (Cancer) 08/2021 - 04/2003
6	Bone Diseases (Bone Disease) 01/2016 - 07/2009
4	Neoplasm Metastasis (Metastasis) 06/2021 - 08/2010
4	Bone Resorption 06/2021 - 10/2007
3	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 06/2005
3	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 11/2011 - 05/2008
2	Disease Progression 01/2022 - 10/2018
2	Hypoxia (Hypoxemia) 12/2021 - 02/2016
2	Breast Neoplasms (Breast Cancer) 02/2019 - 08/2015
2	Prostatic Neoplasms (Prostate Cancer) 01/2017 - 06/2015
2	Renal Cell Carcinoma (Grawitz Tumor) 05/2016 - 06/2015
2	Osteolysis 09/2011 - 03/2010
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 04/2003 - 09/2002
2	Lymphoma (Lymphomas) 04/2003 - 09/2002
1	Urinary Bladder Neoplasms (Bladder Cancer) 07/2022
1	Non-Muscle Invasive Bladder Neoplasms 07/2022
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 05/2022
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2022
1	Toxic Optic Neuropathy 10/2021
1	Melanoma (Melanoma, Malignant) 08/2015
1	Weight Loss (Weight Reduction) 08/2015
1	Kidney Neoplasms (Kidney Cancer) 06/2015
1	Autoimmune Diseases (Autoimmune Disease) 09/2011
1	Polyploidy 05/2011
1	Anemia 10/2010
1	Thrombosis (Thrombus) 10/2010
1	Hypertension (High Blood Pressure) 10/2010
1	Osteoporosis 10/2010

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 12/2021 - 04/2008
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2021 - 02/2007
5	Bortezomib (Velcade)FDA Link 06/2013 - 02/2007
4	Pharmaceutical PreparationsIBA 10/2021 - 02/2014
4	Biological ProductsIBA 06/2013 - 05/2008
4	CytokinesIBA 12/2011 - 06/2005
4	DNA (Deoxyribonucleic Acid)IBA 05/2011 - 06/2007
3	Monoclonal AntibodiesIBA 12/2017 - 06/2009
3	Diphosphonates (Bisphosphonates)IBA 08/2015 - 09/2009
3	Thalidomide (Thalomid)FDA Link 06/2013 - 07/2008
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2009 - 02/2007
2	Azacitidine (5 Azacytidine)FDA Link 05/2022 - 06/2007
2	OsteocalcinIBA 06/2021 - 07/2009
2	Abiraterone AcetateIBA 01/2017 - 06/2015
2	UbiquitinIBA 02/2014 - 11/2009
2	Lenalidomide (CC 5013)FDA Link 06/2013 - 07/2008
2	Immunomodulating AgentsIBA 03/2012 - 07/2008
2	IntegrinsIBA 12/2011 - 11/2009
2	Immunoglobulin G (IgG)IBA 11/2011 - 10/2010
2	TOR Serine-Threonine KinasesIBA 04/2010 - 11/2009
2	MethyltransferasesIBA 11/2009 - 06/2007
2	p38 Mitogen-Activated Protein KinasesIBA 05/2008 - 02/2007
2	Interleukin-6 (Interleukin 6)IBA 02/2008 - 02/2007
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 12/2021
1	selinexorIBA 10/2021
1	belantamab mafodotinIBA 10/2021
1	SARS-CoV-2 spike proteinIBA 08/2021
1	COVID-19 VaccinesIBA 08/2021
1	Indicators and Reagents (Reagents)IBA 06/2021
1	CollagenIBA 06/2021
1	Procollagen Type IIBA 06/2021
1	Drug CombinationsIBA 02/2019
1	Protein Kinase InhibitorsIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	glutamyl- lysyl- alanyl- histidyl- aspartyl- glycyl- glycyl- arginineIBA 10/2018
1	procollagen Type I N-terminal peptideIBA 10/2018
1	elotuzumabIBA 12/2017
1	daratumumabIBA 12/2017
1	cabazitaxel FDA Link 01/2017
1	enzalutamideIBA 01/2017
1	Radium-223IBA 01/2017
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2016
1	capmatinibIBA 01/2016
1	AntimetabolitesIBA 08/2015
1	resazurinIBA 08/2015
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 08/2015
1	5-formyl-2'-deoxyuridineIBA 08/2015
1	5-FdU-alendronateIBA 08/2015
1	abirateroneIBA 06/2015
1	Docetaxel (Taxotere)FDA Link 06/2015
1	Neutralizing AntibodiesIBA 04/2013
1	Anabolic AgentsIBA 12/2011
1	Natalizumab (Tysabri)FDA Link 11/2011
1	LigandsIBA 09/2011
1	ChemokinesIBA 09/2011
1	CCR1 ReceptorsIBA 09/2011
1	1- cyclopropyl- 3- (3- (5- morpholin- 4- ylmethyl- 1H- benzoimidazol- 2- yl)- 1H- pyrazol- 4- yl)ureaIBA 05/2011
1	Aurora Kinase AIBA 05/2011
1	Histones (Histone)IBA 05/2011
1	Aurora KinasesIBA 05/2011
1	Aurora Kinase BIBA 05/2011
1	ActRIIA-mIgG2aFc fusion proteinIBA 10/2010
1	Activin Receptors (Activin Receptor)IBA 10/2010

Therapy/Procedure

8	Therapeutics 10/2021 - 02/2008
6	Drug Therapy (Chemotherapy) 07/2022 - 09/2002
2	Castration 01/2017 - 06/2015
1	Neoadjuvant Therapy 07/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2017
1	Immunotherapy 12/2017
1	Salvage Therapy 05/2016